Digital Diabetes Care Is Expanding Around GLP-1s. The Real Test Is Whether Support Extends Beyond the Prescription.
GLP-1 medicines are changing more than medication lists. They are changing the market for diabetes support. Employers, health plans, clinicians, and patients are all asking versions of the same question: if a person starts a GLP-1 medicine, what happens around the prescription? Who helps them understand side effects, protect nutrition, stay active, navigate coverage, monitor […]
A GLP-1 Prescription Is Not a Complete Care Plan: What Responsible Evaluation and Follow-Up Look Like
GLP-1 medicines have become a major part of conversations about weight, blood sugar, and metabolic health. That visibility has created opportunity: some people who once felt shut out of care are now asking better questions about diabetes, obesity, and long-term risk. It has also created a problem. A medication can be presented online as if […]